drugset / Trial / NCT00844792

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

NCT00844792

Phase 2 Completed 48 enrolled University Health Network, Toronto
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth and prostate cancer aggressiveness.

Timeline

Start
2008-10
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 200 iu
Subject Lycopene Other / unclassified 20 mg
Subject Selenium Other / unclassified 100 ug
Subject Vitamin E Other / unclassified 50 iu
Subject green tea extract Unknown 75 mg

Indications